Trials / Unknown
UnknownNCT02772354
Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes in Pediatric Population
Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes as a First-line Therapy in Pediatric Population Without Structural Heart Disease
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 124 (estimated)
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation · Network
- Sex
- All
- Age
- 7 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effectiveness and safety of catheter ablation of frequent symptomatic PVCs in the pediatric population as first-line therapy compared with antiarrhythmic drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Radiofrequency catheter ablation | Biosense Webster: NAVI-STAR ThermoCool, NAVI-STAR® RMT ThermoCool |
| DRUG | Metoprolol | Antiarrhythmic therapy of premature ventricular complexes Metoprolol 12-50 mg |
| DRUG | Verapamil | Verapamil 20-240 mg |
| DEVICE | NAVI-STAR® RMT ThermoCool |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-09-01
- Completion
- 2018-04-01
- First posted
- 2016-05-13
- Last updated
- 2016-09-09
Locations
2 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT02772354. Inclusion in this directory is not an endorsement.